The National Drug Abuse Treatment Clinical Trials Network (UG1)

Post Date

July 3rd 2014

Application Due Date

December 3rd 2014

Funding Opportunity Number

RFA-DA-15-008

CFDA Number(s)

93.279

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Education
Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Funding

• Estimated Total Funding:

  $15000000

• Award Range:

  $None - $500000

Grant Description

This Funding Opportunity Announcement (FOA) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN).NIDA intends to expand its research to develop and test interventions for the management of the wide spectrum of substance use disorders (SUD) with input from and collaboration with clinical research investigators, healthcare providers, patients and relevant stakeholders. It is expected that successful applicants will describe working alliances with existing and newly created practice-based primary care or other general medical research networks. Through such collaborations, the expanded CTN will execute a comprehensive and staged treatment research agenda to generate the research evidence needed for the integrated management of patients with substance misuse/SUD at general medical settings and linked specialty care treatment settings. This expansion of the CTN also provides an opportunity for community-based SUD treatment provider partners to evaluate integrated and collaborative treatment models for the management of patients with higher-severity SUDs. Together, the CTN will produce much needed, high integrity, evidence-based interventions for a range of substance use problems with the goal of improving the health outcomes of this Nation.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-008.html